Facebook
X
LinkedIn
Forward
GLP-1 Therapies Across the Lifespan: Special Populations and Clinical Implications (NUTRITION 2026 Obesity Collection)
This course is included in the NUTRITION 2026 Obesity Collection.
This session will discuss the use of GLP-1 receptor agonists in unique patient populations, including adolescents, adults, and older adults. Speakers will address nutritional considerations, potential risks, and implications for clinical care and dietary guidance.
Originally presented at NUTRITION 2026, ASN's flagship meeting which was held July 25-28 in National Harbor, MD
Speakers
Monica Agarwal, MD, MEHP, PNS, FACE
University of Alabama at Birmingham
Claire Berryman, PhD, RD
Pennington Biomedical Research Center
Jaime M. Moore, MD, MPH
University of Colorado School of Medicine
Michael Weintraub, MD
NYU Langone Health
Course summary
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.
This activity includes the following presentations:
Welcome and introductions
Claire Berryman, PhD, RD
Pennington Biomedical Research Center
GLP-1 Therapies in Pediatrics
Jaime M. Moore, MD, MPH
University of Colorado School of Medicine
GLP-1 Therapies in Adult Populations
Monica Agarwal, MD, MEHP, PNS, FACE
University of Alabama at Birmingham
GLP-1 Therapies in Older Adults
Michael Weintraub, MD
NYU Langone Health
Panel Discussion / Questions and Answers
Continuing education credit is not available for this activity. A Certificate of Attendance can be downloaded by learners who complete the course.
Available Credit
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.